Oncology Institute, Inc. financial data

Symbol
TOI, TOIIW on Nasdaq, DFPH on OTC
Location
18000 Studebaker Rd, Suite 800, Cerritos, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 179 % -43.7%
Quick Ratio 23.6 % -18%
Debt-to-equity -5.34K % -1313%
Return On Equity 2.1K %
Return On Assets -40.2 % -10.5%
Operating Margin -8.92 % +46.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 98.4M shares +30.2%
Common Stock, Shares, Outstanding 97.6M shares +29.1%
Entity Public Float 34.9M USD -16.1%
Common Stock, Value, Issued 10K USD +25%
Weighted Average Number of Shares Outstanding, Basic 97.5M shares +29.1%
Weighted Average Number of Shares Outstanding, Diluted 97.5M shares +29.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 461M USD +21.7%
Operating Income (Loss) -41.1M USD +35.2%
Nonoperating Income (Expense) -25.3M USD -258%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -66.4M USD +5.87%
Income Tax Expense (Benefit) -131K USD +58.3%
Net Income (Loss) Attributable to Parent -66.3M USD +5.63%
Earnings Per Share, Basic 0 USD/shares +17.9%
Earnings Per Share, Diluted 0 USD/shares +17.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Marketable Securities, Current 0 USD -100%
Accounts Receivable, after Allowance for Credit Loss, Current 59.6M USD +9.43%
Inventory, Net 18.9M USD +86.8%
Assets, Current 110M USD -5.44%
Property, Plant and Equipment, Net 10.7M USD -12.7%
Operating Lease, Right-of-Use Asset 23.3M USD -14.1%
Intangible Assets, Net (Excluding Goodwill) 11.7M USD -24.7%
Goodwill 7.23M USD 0%
Other Assets, Noncurrent 586K USD -0.34%
Assets 164M USD -8.69%
Accounts Payable, Current 35.6M USD +45%
Employee-related Liabilities, Current 8M USD +9.6%
Accrued Liabilities, Current 22.8M USD +47.6%
Contract with Customer, Liability, Current 4.9M USD +255%
Liabilities, Current 65.6M USD +40.3%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 20.2M USD -18.1%
Other Liabilities, Noncurrent 3K USD -97.7%
Liabilities 176M USD +7.45%
Retained Earnings (Accumulated Deficit) -264M USD -33.5%
Stockholders' Equity Attributable to Parent -12.3M USD -179%
Liabilities and Equity 164M USD -8.69%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.99M USD +68.6%
Net Cash Provided by (Used in) Financing Activities -4.74M USD -405%
Net Cash Provided by (Used in) Investing Activities -202K USD -101%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 99.3M shares +28.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 27.7M USD -41.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.29M USD +13.8%
Deferred Tax Assets, Valuation Allowance 63.6M USD +17.8%
Deferred Tax Assets, Gross 72.8M USD +13.4%
Operating Lease, Liability 27.4M USD -12.9%
Depreciation 3.98M USD +29.8%
Payments to Acquire Property, Plant, and Equipment 328K USD -46.2%
Lessee, Operating Lease, Liability, to be Paid 31.7M USD -14.5%
Operating Lease, Liability, Current 7.16M USD +6.11%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.47M USD -6.79%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.59M USD +1.56%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.31M USD -23.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.57M USD -18.2%
Deferred Tax Assets, Operating Loss Carryforwards 53.4M USD +32.4%
Preferred Stock, Shares Issued 194K shares +17.2%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 99K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.91M USD -17.8%
Operating Lease, Payments 2.21M USD +7.98%
Additional Paid in Capital 253M USD +18%
Preferred Stock, Shares Outstanding 194K shares +17.2%
Amortization of Intangible Assets 3.04M USD -1.75%
Depreciation, Depletion and Amortization 1.78M USD +19.8%
Deferred Tax Assets, Net of Valuation Allowance 9.19M USD -9.73%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%